Search Login Register

tripeptidyl-peptidase 1 Summary

Description: releases N-terminal tripeptides from polypeptides; involved in the degradation of bone collagen; mutations in gene are associated with the Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL); RefSeq NM_000391 (human); NM_009906 (mouse); NM_031357 (rat)

Also Known As: CLN2 protein, human; Cln2 protein, mouse; Cln2 protein, rat; TPP-I protein, human; TPP1 protein, human Show All >>

Networked: 60 relevant articles (0 outcomes, 2 trials/studies) for this Bio-Agent

Key Diseases for which tripeptidyl-peptidase 1 is Relevant

  1. Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) : 1 study in 53 results
  2. Rheumatoid Arthritis : 1 study in 1 result
  3. Neurodegenerative Diseases (Neurodegenerative Disease) : 14 results
  4. Lysosomal Storage Diseases (Lysosomal Storage Disease) : 4 results
  5. Nervous System Heredodegenerative Disorders : 2 results
Show All >>

Drugs Related to tripeptidyl-peptidase 1

  1. Serine Proteases (Serine Protease)
  2. Cathepsin C
  3. Cysteine Proteases (Cysteine Protease)
  4. Lysergic Acid Diethylamide (LSD)
  5. Glycoside Hydrolases (Endoglycosidases)
  6. Collagen
  7. Cathepsin D
  8. Cathepsin B
  9. Aspartic Acid (Aspartate)
  10. dipeptidyl peptidase II
Show All >>

Therapies Related to tripeptidyl-peptidase 1

  1. Therapeutics

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.